Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 114, 2008 - Issue 5
282
Views
22
CrossRef citations to date
0
Altmetric
Review Article

Adipose tissue and skeletal muscle plasticity modulates metabolic health

, , , &
Pages 357-368 | Received 03 Jul 2008, Accepted 22 Sep 2008, Published online: 05 Jan 2009

References

  • P Aguiari, S Leo, B Zavan, V Vindigni, A Rimessi, K Bianchi, C Franzin, R Cortivo, M Rossato, R Vettor, and et al (2008). High glucose induces adipogenic differentiation of muscle-derived stem cells. Proc Natl Acad Sci USA 105 (4):1226–1231.
  • R S Ahima, and M A Lazar. (2008). Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 00:00–00.
  • M A Alpert, M A Fraley, J A Birchem, and N Senkottaiyan. (2005). Management of obesity cardiomyopathy. Expert Rev Cardiovasc Ther 3 (2):225–230.
  • K M Baldwin, and F Haddad. (2002). Skeletal muscle plasticity: cellular and molecular responses to altered physical activity paradigms. Am J Phys Med Rehabil 81 (11 Suppl):S40–S51.
  • Y Bao, C Bing, L Hunter, J R Jenkins, M Wabitsch, and P Trayhurn. (2005). Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human SGBS adipocytes. FEBS Lett 579 (1):41–47.
  • R Bar-Shalom, D Gaitini, Z Keidar, and O Israel. (2004). Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. Eur J Nucl Med Mol Imaging 31 (8):1105–1113.
  • B Barrilleaux, D G Phinney, D J Prockop, and K C O'Connor. (2006). Review: ex vivo engineering of living tissues with adult stem cells. Tissue Eng 12 (11):3007–3019.
  • T J Bartness, C Kay Song, H Shi, R R Bowers, and M T Foster. (2005). Brain-adipose tissue cross talk. Proc Nutr Soc 64 (1):53–64.
  • H Bays. (2005). Adiposopathy, metabolic syndrome, quantum physics, general relativity, chaos and the theory of everything. Expert Rev Cardiovasc Ther 3 (3):393–404.
  • H Bays, L Blonde, and R Rosenson. (2006). Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients. Expert Rev Cardiovasc Ther 4 (6):871–895.
  • H E Bays, J M Gonzalez-Campoy, G A Bray, A E Kitabchi, D A Bergman, A B Schorr, H W Rodbard, and R R Henry. (2008). Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 6 (3):343–368.
  • I Bogacka, H Xie, G A Bray, and S R Smith. (2005). Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 54 (5):1392–1399.
  • D R Bolster, S R Kimball, and L S Jefferson. (2003). Translational control mechanisms modulate skeletal muscle gene expression during hypertrophy. Exerc Sport Sci Rev 31 (3):111–116.
  • P Bostrom, B Magnusson, P A Svensson, O Wiklund, J Boren, L M Carlsson, M Stahlman, S O Olofsson, and L M Hulten. (2006). Hypoxia converts human macrophages into triglyceride-loaded foam cells. Arterioscler Thromb Vasc Biol 26 (8):1871–1876.
  • C Broholm, O H Mortensen, S Nielsen, T Akerstrom, A Zankari, B Dahl, and B K Pedersen. (2008). Exercise induces expression of Leukemia Inhibitory Factor LIF in human skeletal muscle. J Physiol 00:00–00.
  • B Cannon, and J Nedergaard. (2004). Brown adipose tissue: function and physiological significance. Physiol Rev 84 (1):277–359.
  • A Carriere, M C Carmona, Y Fernandez, M Rigoulet, R H Wenger, L Penicaud, and L Casteilla. (2004). Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect. J Biol Chem 279 (39):40462–40469.
  • L Casteilla, and C Dani. (2006). Adipose tissue-derived cells: from physiology to regenerative medicine. Diabetes Metab 32 (5 Pt 1):393–401.
  • N S Chandel, and G R Budinger. (2007). The cellular basis for diverse responses to oxygen. Free Radic Biol Med 42 (2):165–174.
  • C Chavey, B Mari, M N Monthouel, S Bonnafous, P Anglard, E Van Obberghen, and S Tartare-Deckert. (2003). Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 278 (14):11888–11896.
  • S Collins, W Cao, and J Robidoux. (2004). Learning new tricks from old dogs: beta-adrenergic receptors teach new lessons on firing up adipose tissue metabolism. Mol Endocrinol 18 (9):2123–2131.
  • T Cramer, and R S Johnson. (2003). A novel role for the hypoxia inducible transcription factor HIF-1alpha: critical regulation of inflammatory cell function. Cell Cycle 2 (3):192–193.
  • T Cramer, Y Yamanishi, B E Clausen, I Forster, R Pawlinski, N Mackman, V H Haase, R Jaenisch, M Corr, V Nizet, and et al (2003). HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112 (5):645–657.
  • M Daval, F Foufelle, and P Ferré. (2006). Functions of AMP-activated protein kinase in adipose tissue. J Physiol 574 (Pt 1):55–62.
  • R A DeFronzo. (2004). Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract 143 (Suppl):9–21.
  • J Delarue, and C Magnan. (2007). Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 10 (2):142–148.
  • E Erbay, H Cao, and G S Hotamisligil. (2007). Adipocyte/macrophage fatty acid binding proteins in metabolic syndrome. Curr Atheroscler Rep 9 (3):222–229.
  • G Fantuzzi. (2005). Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115 (5):911–919. quiz 920
  • S R Farmer. (2006). Transcriptional control of adipocyte formation. Cell Metab 4 (4):263–273.
  • M Fluck. (2006). Functional, structural and molecular plasticity of mammalian skeletal muscle in response to exercise stimuli. J Exp Biol 209 (Pt 12):2239–2248.
  • M Fluck, and H Hoppeler. (2003). Molecular basis of skeletal muscle plasticity – from gene to form and function. Rev Physiol Biochem Pharmacol 146:159–216.
  • C S Fox, J M Massaro, U Hoffmann, K M Pou, P Maurovich-Horvat, C Y Liu, R S Vasan, J M Murabito, J B Meigs, L A Cupples, and et al (2007). Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116 (1):39–48.
  • D Freyssenet, I Irrcher, M K Connor, M Di Carlo, and D A Hood. (2004). Calcium-regulated changes in mitochondrial phenotype in skeletal muscle cells. Am J Physiol Cell Physiol 286 (5):C1053–C1061.
  • D Freyssenet. (2007). Energy sensing and regulation of gene expression in skeletal muscle. J Appl Physiol 102 (2):529–540.
  • C A Garcia, D Van Nostrand, D Van Nostrand, F Atkins, E Acio, C Butler, G Esposito, K Kulkarni, and M Majd. (2006). Reduction of brown fat 2-deoxy-2-[F-18]fluoro-D-glucose uptake by controlling environmental temperature prior to positron emission tomography scan. Mol Imaging Biol 8 (1):24–29.
  • C A Garcia, D Van Nostrand, M Majd, F Atkins, E Acio, A Sheikh, and C Butler. (2004). Benzodiazepine-resistant brown fat pattern in positron emission tomography: two case reports of resolution with temperature control. Mol Imaging Biol 6 (6):368–372.
  • M S Gauthier, H Miyoshi, S C Souza, J M Cacicedo, A K Saha, A S Greenberg, and N B Ruderman. (2008). AMP-activated protein kinase is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance. J Biol Chem 283 (24):16514–16524.
  • L Ghizzoni, G Mastorakos, M Ziveri, M Furlini, A Solazzi, A Vottero, and S Bernasconi. (2001). Interactions of leptin and thyrotropin 24-hour secretory profiles in short normal children. J Clin Endocrinol Metab 86 (5):2065–2072.
  • G H Goossens. (2007). The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav 00:00–00.
  • S Gordon. (2007). Macrophage heterogeneity and tissue lipids. J Clin Invest 117 (1):89–93.
  • S Gordon, and P R Taylor. (2005). Monocyte and macrophage heterogeneity. Nat Rev Immunol 5 (12):953–964.
  • J G Granneman, M Burnazi, Z Zhu, and L A Schwamb. (2003). White adipose tissue contributes to UCP1-independent thermogenesis. Am J Physiol Endocrinol Metab 285 (6):E1230–E1236.
  • R M Grumbles, G T Casella, M J Rudinsky, P M Wood, S Sesodia, M Bent, and C K Thomas. (2007). Long-term delivery of FGF-6 changes the fiber type and fatigability of muscle reinnervated from embryonic neurons transplanted into adult rat peripheral nerve. J Neurosci Res 85 (9):1933–1942.
  • F Guilak, K E Lott, H A Awad, Q Cao, K C Hicok, B Fermor, and J M Gimble. (2006). Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J Cell Physiol 206 (1):229–237.
  • O Hamdy, S Porramatikul, and E Al-Ozairi. (2006). Metabolic obesity:the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2 (4):367–373.
  • J Himms-Hagen. (2004). Exercise in a pill: feasibility of energy expenditure targets. Curr Drug Targets CNS Neurol Disord 3 (5):389–409.
  • K Hirai, H J Hussey, M D Barber, S A Price, and M J Tisdale. (1998). Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res 58 (11):2359–2365.
  • S L Hocking, D J Chisholm, and D E James. (2008). Studies of regional adipose transplantation reveal a unique and beneficial interaction between subcutaneous adipose tissue and the intra-abdominal compartment. Diabetologia 51 (5):900–902.
  • N Hosogai, A Fukuhara, K Oshima, Y Miyata, S Tanaka, K Segawa, S Furukawa, Y Tochino, R Komuro, M Matsuda, and I Shimomura. (2007). Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56 (4):901–911.
  • G Hu, J Tuomilehto, K Silventoinen, N C Barengo, M Peltonen, and P Jousilahti. (2005). The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47 212 middle-aged Finnish men and women. Int J Obes Lond 29 (8):894–902.
  • L E Huang, J Gu, M Schau, and H F Bunn. (1998). Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95 (14):7987–7992.
  • J Huber, M Loffler, M Bilban, M Reimers, A Kadl, J Todoric, M Zeyda, R Geyeregger, M Schreiner, T Weichhart, N Leitinger, W Waldhausl, and T M Stulnig. (2007). Prevention of high-fat diet-induced adipose tissue remodelling in obese diabetic mice by n-3 polyunsaturated fatty acids. Int J Obes Lond 31 (6):1004–1013.
  • K E Inouye, H Shi, J K Howard, C H Daly, G M Lord, B J Rollins, and J S Flier. (2007). Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes 56 (9):2242–2250.
  • M D Jensen. (2006). Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity Silver Spring 14 (Suppl 1):20S–24S.
  • P Jezek, M Zackova, M Ruzicka, E Skobisova, and M Jaburek. (2004). Mitochondrial uncoupling proteins – facts and fantasies. Physiol Res 53 (Suppl 1):S199–S211.
  • B I Joffe, V R Panz, and F J Raal. (2001). From lipodystrophy syndromes to diabetes mellitus. Lancet 357 (9266):1379–1381.
  • A M Joseph, H Pilegaard, A Litvintsev, L Leick, and D A Hood. (2006). Control of gene expression and mitochondrial biogenesis in the muscular adaptation to endurance exercise. Essays Biochem 42:13–29.
  • M Kabir, K J Catalano, S Ananthnarayan, S P Kim, G W Van Citters, M K Dea, and R N Bergman. (2005). Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 288 (2):E454–E461.
  • N Kamei, K Tobe, R Suzuki, M Ohsugi, T Watanabe, N Kubota, N Ohtsuka-Kowatari, K Kumagai, K Sakamoto, M Kobayashi, and T Yamauchi. (2006). Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281 (36):26602–26614.
  • H Kanda, S Tateya, Y Tamori, K Kotani, K Hiasa, R Kitazawa, S Kitazawa, H Miyachi, S Maeda, K Egashira, and M Kasuga. (2006). MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116 (6):1494–1505.
  • L J Kelly, P P Vicario, G M Thompson, M R Candelore, T W Doebber, J Ventre, M S Wu, R Meurer, M J Forrest, M W Conner, M A Cascieri, and D E Moller. (1998). Peroxisome proliferators-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein UCP-1, UCP-2, UCP-3 gene expression. Endocrinology 139 (12):4920–4927.
  • K H Kim, M J Song, J Chung, H Park, and J B Kim. (2005). Hypoxia inhibits adipocyte differentiation in a HDAC-independent manner. Biochem Biophys Res Commun 333 (4):1178–1184.
  • U Kintscher, M Hartge, K Hess, A Foryst-Ludwig, M Clemenz, M Wabitsch, P Fischer-Posovszky, T F Barth, D Dragun, T Skurk, and et al (2008). T-lymphocyte infiltration in visceral adipose tissue. A primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 28 (7):1304–1310.
  • S Kralisch, J Klein, U Lossner, M Bluher, R Paschke, M Stumvoll, and M Fasshauer. (2005). Proinflammatory adipocytokines induce TIMP-1 expression in 3T3-L1 adipocytes. FEBS Lett 579 (28):6417–6422.
  • S Kralisch, U Lossner, M Bluher, R Paschke, M Stumvoll, and M Fasshauer. (2006). Tissue inhibitor of metalloproteinase 1 expression and secretion are induced by beta–adrenergic stimulation in 3T3-L1 adipocytes. J Endocrinol 189 (3):665–670.
  • M Lehrke, and M A Lazar. (2005). The many faces of PPARgamma. Cell 123 (6):993–999.
  • P Li, Z Zhu, Y Lu, and J G Granneman. (2005). Metabolic and cellular plasticity in white adipose tissue II: role of peroxisome proliferators-activated receptor-alpha. Am J Physiol Endocrinol Metab 289 (4):E617–E626.
  • H R Lijnen, D Demeulemeester, B Van Hoef, D Collen, and E Maquoi. (2003). Deficiency of tissue inhibitor of matrix metalloproteinase-1 TIMP-1 impairs nutritionally induced obesity in mice. Thromb Haemost 89 (2):249–255.
  • J Lilla, D Stickens, and Z Werb. (2002). Metalloproteases and adipogenesis: a weighty subject. Am J Pathol 160 (5):1551–1554.
  • M F Linton, and S Fazio. (2003). Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord 27 (Suppl 3):S35–S40.
  • L Liu, and M C Simon. (2004). Regulation of transcription and translation by hypoxia. Cancer Biol Ther 3 (6):492–497.
  • C N Lumeng, J L Bodzin, and A R Saltiel. (2007). Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117 (1):175–184.
  • E Maquoi, C Munaut, A Colige, D Collen, and H R Lijnen. (2002). Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 51 (4):1093–1101.
  • M P Marrades, J A Martínez, and M J Moreno-Aliaga. (2008). ZAG, a lipid mobilizing adipokine, is downregulated in human obesity. J Physiol Biochem 64 (1):61–66.
  • D M Muoio, and T R Koves. (2007). Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic disease. Appl Physiol Nutr Metab 32 (5):874–883.
  • J Nedergaard, T Bengtsson, and B Cannon. (2007). Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 293 (2):E444–E452.
  • J G Neels, and J M Olefsky. (2006). Inflamed fat: what starts the fire. J Clin Invest 116 (1):33–35.
  • A R Nielsen, and B K Pedersen. (2007). The biological roles of exercise-induced cytokines:IL-6, IL-8, and IL-15. Appl Physiol Nutr Metab 32 (5):833–839.
  • T Nomiyama, D Perez-Tilve, D Ogawa, F Gizard, Y Zhao, E B Heywood, K L Jones, R Kawamori, L A Cassis, M H Tschop, and D Bruemmer. (2007). Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 117 (10):2877–2888.
  • A V Nunn, J Bell, and P Barter. (2007). The integration of lipid-sensing and anti-inflammatory effects: how the PPARs play a role in metabolic balance. Nucl Recept 5 (1):1.
  • J I Odegaard, R R Ricardo-Gonzalez, M H Goforth, C R Morel, V Subramanian, L Mukundan, A R Eagle, D Vats, F Brombacher, A W Ferrante, and A Chawla. (2007). Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447 (7148):1116–1120.
  • O Parysow, A M Mollerach, V Jager, S Racioppi, J San Roman, and V H Gerbaudo. (2007). Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans. Clin Nucl Med 32 (5):351–357.
  • B K Pedersen. (2007). IL-6 signalling in exercise and disease. Biochem Soc Trans 35 (Pt 5):1295–1297.
  • B K Pedersen, T C Akerstrom, A R Nielsen, and C P Fischer. (2007). Role of myokines in exercise and metabolism. J Appl Physiol 103 (3):1093–1098.
  • B K Pedersen, and M Febbraio. (2005). Muscle-derived interleukin-6 – a possible link between skeletal muscle, adipose tissue, liver, and brain. Brain Behav Immun 19 (5):371–376.
  • B K Pedersen, A Steensberg, and P Schjerling. (2001). Exercise and interleukin-6. Curr Opin Hematol 8 (3):137–141.
  • P Plomgaard, P Keller, C Keller, and B K Pedersen. (2005). TNF-alpha, but not IL-6, stimulates plasminogen activator inhibitor-1 expression in human subcutaneous adipose tissue. J Appl Physiol 98 (6):2019–2023.
  • C Ramacciotti, O Schneegans, H Lang, V Lindner, M Claria, F Moreau, M P Chenard, M Pinget, and L Kessler. (2006). Diffuse uptake of brown fat on computed-tomography coupled positron emission tomoscintigraphy PET-CT for the exploration of extra-adrenal pheochromocytoma. Ann Endocrinol Paris 67 (1):14–19.
  • E Ravussin, and S R Smith. (2002). Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci 967:363–378.
  • J X Rong, Y Qiu, M K Hansen, L Zhu, V Zhang, M Xie, Y Okamoto, M D Mattie, H Higashiyama, S Asano, J C Strum, and T E Ryan. (2007). Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone. Diabetes 56 (7):1751–1760.
  • E D Rosen, C H Hsu, X Wang, S Sakai, M W Freeman, F J Gonzalez, and B M Spiegelman. (2002). C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev 16 (1):22–26.
  • G P Rossi, D Sticchi, L Giuliani, P Bernante, S Zavattiero, A C Pessina, and G G Nussdorfer. (2006). Adiponectin receptor expression in the human adrenal cortex and aldosterone–producing adenomas. Int J Mol Med 17 (6):975–980.
  • N B Ruderman, C Keller, A M Richard, A K Saha, Z Luo, X Xiang, M Giralt, V B Ritov, E V Menshikova, D E Kelley, J Hidalgo, B K Pedersen, and M Kelly. (2006). Interleukin-6 regulation of AMP-activated protein kinase. Potential role in the systemic response to exercise and prevention of the metabolic syndrome. Diabetes 55 (Suppl 2):S48–S54.
  • J E Rundhaug. (2005). Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9 (2):267–285.
  • S T Russell, and M J Tisdale. (2005). Effect of eicosapentaenoic acid EPA on expression of a lipid mobilizing factor in adipose tissue in cancer cachexia. Prostaglandins Leukot Essent Fatty Acids 72 (6):409–414.
  • S Samec, J Seydoux, and A G Dulloo. (1998). Interorgan signalling between adipose tissue metabolism and skeletal muscle uncoupling protein homologs: is there a role for circulating free fatty acids. Diabetes 47 (11):1693–1698.
  • A Schaffler, J Scholmerich, and C Buchler. (2005a). Mechanisms of disease:adipocytokines and visceral adipose tissue – emerging role in intestinal and mesenteric diseases. Nat Clin Pract Gastroenterol Hepatol 2 (2):103–111.
  • A Schaffler, J Scholmerich, and C Buchler. (2005b). Mechanisms of disease: adipocytokines and visceral adipose tissue – emerging role in nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2 (6):273–280.
  • A Schmidt, S Bierwirth, S Weber, P Platen, T Schinkothe, and W Bloch. (2007). Short intensive exercise increase the migratory activity of mesenchymal stem cells. Br J Sports Med .
  • P Seale, B Bjork, W Yang, S Kajimura, S Chin, S Kuang, A Scime, S Devarakonda, H M Conroe, H Erdjument-Bromage, and et al (2008). PRDM16 controls a brown fat/skeletal muscle switch. Nature 454 (7207):961–967.
  • H Sell, D Dietze-Schroeder, and J Eckel. (2006). The adipocyte-myocyte axis in insulin resistance. Trends Endocrinol Metab 17 (10):416–422.
  • H Sell, K Eckardt, A Taube, D Tews, M Gurgui, G Van Echten-Deckert, and J Eckel. (2008). Skeletal muscle insulin resistance induced by adipocyte-conditioned medium: underlying mechanisms and reversibility. Am J Physiol Endocrinol Metab 294 (6):E1070–E1077.
  • G L Semenza. (2000). HIF-1 and human disease: one highly involved factor. Genes Dev 14 (16):1983–1991.
  • J K Sethi, and A J Vidal-Puig. (2007). Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res 48 (6):1253–1262.
  • M Shibasaki, K Takahashi, T Itou, S Miyazawa, M Ito, J Kobayashi, H Bujo, and Y Saito. (2002). Alterations of insulin sensitivity by the implantation of 3T3-L1 cells in nude mice. A role for TNF-alpha. Diabetologia 454:518–526.
  • M Skopkova, A Penesova, H Sell, Z Radikova, M Vlcek, R Imrich, J Koska, J Ukropec, J Eckel, I Klimes, and D Gasperikova. (2007). Protein array reveals differentially expressed proteins in subcutaneous adipose tissue in obesity. Obesity Silver Spring 15 (10):2396–2406.
  • J Sponarova, K J Mustard, O Horakova, P Flachs, M Rossmeisl, P Brauner, K Bardova, M Thomason-Hughes, R Braunerova, P Janovska, D G Hardie, and J Kopecky. (2005). Involvement of AMP-activated protein kinase in fat depot-specific metabolic changes during starvation. FEBS Lett 579 (27):6105–6110.
  • A Tchernof. (2007). Visceral adipocytes and the metabolic syndrome. Nutr Rev 65 (6 Pt 2):S24–S29.
  • T T Tran, Y Yamamoto, S Gesta, and C R Kahn. (2008). Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 7 (5):410–420.
  • P Trayhurn. (2005). The biology of obesity. Proc Nutr Soc 64 (1):31–38.
  • P Trayhurn, C Bing, and I S Wood. (2006). Adipose tissue and adipokines – energy regulation from the human perspective. J Nutr 136 (7 Suppl):1935S–1939S.
  • P Trayhurn, and I S Wood. (2005). Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 33 (Pt 5):1078–1081.
  • Y H Tseng, E Kokkotou, T J Schulz, T L Huang, J N Winnay, C M Taniguchi, T T Tran, R Suzuki, D O Espinoza, Y Yamamoto, and et al (2008). New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454 (7207):1000–1004.
  • J Ukropec, R P Anunciado, Y Ravussin, M W Hulver, and L P Kozak. (2006). UCP1-independent thermogenesis in white adipose tissue of cold-acclimated Ucp1-/mice. J Biol Chem 281 (42):31894–31908.
  • J Ukropec, A Penesová, M Škopková, M Pura, M Vlček, Z Rádiková, R Imrich, B Ukropcová, M Tajtáková, J Koška, and et al (2008). Adipokine protein expression pattern in growth hormone deficiency predisposes to the increased fat cell size and to the whole body metabolic derangements. J Clin Endocrinol and Metab 93 (6):2255–2262.
  • R H Unger. (2002). Lipotoxic diseases. Annu Rev Med 53:319–336.
  • K Uno, H Katagiri, T Yamada, Y Ishigaki, T Ogihara, J Imai, Y Hasegawa, J Gao, K Kaneko, H Iwasaki, and et al (2006). Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science 312 (5780):1656–1659.
  • E Valassi, M Scacchi, and F Cavagnini. (2008). Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis 18 (2):158–168.
  • L E Wagenknecht, C D Langefeld, A L Scherzinger, J M Norris, S M Haffner, M F Saad, and R N Bergman. (2003). Insulin sensitivity, insulin secretion, and abdominal fat:the Insulin Resistance Atherosclerosis Study IRAS Family Study. Diabetes 52 (10):2490–2496.
  • B L Wajchenberg. (2000). Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21 (6):697–738.
  • H Waki, K W Park, N Mitro, L Pei, R Damoiseaux, D C Wilpitz, K Reue, E Saez, and P Tontonoz. (2007). The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression. Cell Metab 5 (5):357–370.
  • B Wang, I S Wood, and P Trayhurn. (2007). Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch 455 (3):479–492.
  • B Wang, I S Wood, and P Trayhurn. (2008). PCR arrays identify metallothionein-3 as a highly hypoxia-inducible gene in human adipocytes. Biochem Biophys Res Commun 368 (1):88–93.
  • H Wang, Y Zhang, E Yehuda-Shnaidman, A V Medvedev, N Kumar, K W Daniel, J Robidoux, M P Czech, D J Mangelsdorf, and S Collins. (2008). Liver X receptor alpha is a transcriptional repressor of the uncoupling protein 1 gene and the brown fat phenotype. Mol Cell Biol 28 (7):2187–2200.
  • S P Weisberg, D Hunter, R Huber, J Lemieux, S Slaymaker, K Vaddi, I Charo, R L Leibel, and A W FerranteJr.. (2006). CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 1161:115–124.
  • R Weiss. (2007). Fat distribution and storage:how much, where, and how. Eur J Endocrinol 157 (Suppl 1):S39–S45.
  • K E Wellen, and G S Hotamisligil. (2005). Inflammation, stress, and diabetes. J Clin Invest 115 (5):1111–1119.
  • C Weyer, J E Foley, C Bogardus, P A Tataranni, and R E Pratley. (2000). Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43 (12):1498–1506.
  • L Wilson-Fritch, A Burkart, G Bell, K Mendelson, J Leszyk, S Nicolon, M Czech, and S Corvera. (2003). Mitochondrial biogenesis and remodelling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol Cell Biol 23 (3):1085–1094.
  • W W Winder, and D M Thomson. (2007). Cellular energy sensing and signalling by AMP-activated protein kinase. Cell Biochem Biophys 47 (3):332–347.
  • D C Wright, P C Geiger, D H Han, T E Jones, and J O Holloszy. (2007). Calcium induces increases in peroxisome proliferators-activated receptor gamma coactivator-1alpha and mitochondrial biogenesis by a pathway leading to p38 mitogen-activated protein kinase activation. J Biol Chem 282 (26):18793–18799.
  • M Yamauchi, F Kambe, X Cao, X Lu, Y Kozaki, Y Oiso, and H Seo. (2008). Thyroid hormone activates AMP-activated protein kinase via intracellular calcium mobilization and activation of calcium/calmodulin-dependent protein kinase kinase-{beta}. Mol Endocrinol 00:00–00.
  • J Ye, Z Gao, J Yin, and Q He. (2007). Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293 (4):E1118–E1128.
  • Z Yun, H L Maecker, R S Johnson, and A J Giaccia. (2002). Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell 2 (3):331–341.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.